Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
20.86
-2.14 (-9.30%)
At close: Oct 28, 2025, 4:00 PM EDT
21.35
+0.49 (2.35%)
After-hours: Oct 28, 2025, 7:01 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $44.77 million as of October 28, 2025. Its market cap has increased by 197.15% in one year.
Market Cap
44.77M
Enterprise Value
35.95M
1-Year Change
197.15%
Ranking
Category
Stock Price
$20.86
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $44.77M, a decrease of -65.45%. That is a compound annual growth rate of -23.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 49.36M | 359.13% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |